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OBJECTIVES: To characterize the real-world profile of heart failure (HF) patients
with reduced ejection fraction (REF) and their treatment patterns in China.
METHODS: A retrospective chart review was conducted in 9 hospitals in 5 key
regions (Beijing, Shanghai, Wuhan, Chengdu, Guangzhou) to capture patient pro-
files and to evaluate treatment patterns in patients following hospitalization for
HF. Patients hospitalized for HF in 2005-2008 were identified. A total of 805 HF
subjects’ charts were selected and reviewed for health care treatment between
2000 and 2011. Data were collected from the first HF hospitalization until the last
date of data entry or death. RESULTS: A total of 460 patients with HF-REF and at
least one hospitalization were followed for an average of 2.86 years. Patients were
aged 61.814.12, and 65.9% were male. On average, HF-REF patients had 2.02.30
hospitalizations during follow-up. At the first hospitalization, severity was most
frequently New York Heart Association (NYHA) Class III in 46.4% of patients, fol-
lowed by Class IV in 27.1% and Class II in 26.0%. HF severity increased with subse-
quent hospitalizations. The most common etiologic/comorbid conditions were
idiopathic dilated cardiomyopathy (49.3%) followed by hypertension (42.2%), atrial
fibrillation (24.1%) and ischemic heart disease (20.2%). Median length of stay for the
first hospitalization was 10 days with the subsequent 3 hospitalizations ranging
between 8-9 days. The overall death rate during the follow-up period was 19.35%
with regional variance; 0% in Shanghai to 32% in Wuhan; however Shanghai sub-
jects had milder HF. The mean time to death was 747.0568.9 days from first
hospitalization for thosewho died (median: 779.0).CONCLUSIONS:This large chart
review provides a recent, real-world patient profile of HF-REF patients following
hospitalization for HF in China. Heart failure treatment presents a large burden to
the health care system in the 5 major regions in China, with some regional
variations.
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OBJECTIVES: Atrial fibrillation (AF), the most common sustained arrhythmia, con-
fers an increased risk of death in patients with myocardial infarction (MI). The
onset of AF in relation to MI differentially impacts survival, with AF developing
after MI corresponding to the worst survival. However, the impact of AF and its
timing on healthcare resource utilization after MI is unknown.METHODS: The risk
of hospitalization, emergency department (ED) visits, and outpatient office visits
associated with prior, early-onset (30 days post-MI) and late-onset (30 days
post-MI) AF was assessed among incident MI patients from 2002–2009 in the com-
munity. Andersen-Gill modeling was used to predict hospitalizations and ED visits
by AF category, whereas negative binomial regression was used for outpatient
visits. RESULTS: Of 1362 MI patients (mean age 6815, 57%men), 221 had prior AF,
134 developed early-onset AF, 96 developed late-onset AF, and 911 had no AF. Over
a mean of 3.7 years, 3335 hospitalizations, 4940 ED visits, and 70,632 outpatient
visits occurred. After adjustment, as compared to those without AF, patients with
prior and early-onset AF exhibited a 1.5-fold and 1.3-fold increased risk of hospi-
talization, respectively. In contrast, late-onset AF carried a 2.1-fold increased risk of
hospitalization. The corresponding hazard ratios for ED visits were 1.4, 1.2, and 1.7
for prior, early-onset, and late-onset AF, respectively. Surprisingly, the risk of out-
patient visits did not differ by the timing of AF, and only a 1.3-fold increased risk
was observed for late-onset AF.CONCLUSIONS:AmongpatientswithMI, the risk of
subsequent hospitalizations and ED visits differed markedly according to the tim-
ing of AF, with approximately twice the risk among those developing late-onset AF
compared to MI patients without AF. AF is an adverse prognostic indicator in MI
and these data underscore the importance of its management in MI patients.
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OBJECTIVES: To evaluate the profile of patients undergoing hip replacement (THR)
or knee replacement (TKR) surgery and the associated costs with surgery according
to public health care system (SUS) perspective. METHODS: A review of a govern-
ment administrative claims database (DATASUS) was conducted for patients who
underwent a THR or TKR procedure between January 2009 to March 2011. Data
regarding gender, age and mean costs per patients were analyzed for the entire
period and data for procedures costs were collected per year, as some of themwere
excluded from SUS procedure list. RESULTS: A total of 41,862 patients were iden-
tified at study period (12,476 for TKR and 29,386 THR). Average agewas 65,6 (SD 10,5)
for TKR and 64,1(SD 14,9) for THR, being women more frequently submitted to
surgery than men (71,7% vs 28,3% for TKR and 55,7% vs 44,3% for THR). Mean
hospitalizations costs per patient was $BRL4,203 (SD $BRL2,115) and $BRL4,130 (SD
$BRL2,145) for TKR and THR respectively. When comparing expenses according to
procedures groups, prostheses represented 76,9% and 76,8% of total costs in 2009
and 2010 respectively, followed by health care professionals. CONCLUSIONS:More
than 40,000 total arthroplasty surgeries were performed in SUS from January 2009
until March 2011, when THR accounted for approximately 70% of all cases. Mean
age for patients submitted to surgery were similar for both procedures, being
women more frequently undertaking surgery than man. When considering all
costs associated to arthroplasty, total expenses were similar in both groups. How-
ever, when compared with costs reported at the private system (described else-
where), expenses in SUS represents about 12%.
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OBJECTIVES: Acute heart failure (AHF) is a mounting problem worldwide, with
significant economic burden. Renal impairment is common among patients with
AHF but its full economic implications are unknown. The study aims to describe
and compare medical resource utilization and costs among AHF patients with and
without renal impairment.METHODS: Patients with1 hospitalization with a pri-
mary diagnosis of AHF continuously enrolled for 6 months of baseline period
prior to the first hospitalization (FH) were identified in the US MarketScan claims
database (2004-2008). History of renal impairmentwas identified using ICD-9 codes
at baseline or FH. Patients were observed for 12 months post FH or until insurance
disenrollment. Measured outcomes include inpatient resource utilization, hospital
length of stay (LOS) and costs. Rates of hospital re-admissions, outpatient visits
and costs were calculated per patient per month (PPPM). RESULTS: A total of 6396
AHF patients (mean age 73.6 years, 50.6% female) were studied; 1082 (17%) had
renal impairment. At FH, renal patients hadmore comorbidities, longer LOS (7.0 vs.
7.9 days), and similar costs ($15,820 vs. $15,467) compared to non-renal patients.
The average cost per re-hospitalization was $17,887 vs. $16,780 for renal vs. non-
renal patients, with average LOS of 7.9 and 6.5 days, respectively. Throughout the
study period, re-hospitalization, outpatient visit rates and costs PPPM were signif-
icantly (P0.05) higher among renal compared to non-renal patients, with highest
costs and rates observed within 3 months of FH ($2,480 vs. $1,421 total healthcare
cost PPPM; 0.063 vs. 0.024 re-hospitalization PPPM and; 1.406 vs. 1.051 outpatient
visits PPPM). CONCLUSIONS: AHF patients with renal impairment are resource
intensive and a costly subgroup of AHF population. Their increased use of outpa-
tient services despite having longer, more frequent hospitalizations suggest an
unmet need thus, new therapies that reduce re-hospitalizations may offer mean-
ingful cost savings and improved health outcomes.
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OBJECTIVES: As the primary care sector does not bear the direct costs of hospital-
ization, it may under-invest in prevention to avoid hospitalizations. This could
increase overall primary care spending if hospitalizations are associated with sub-
sequent increases in primary care resource use. The objectives of this studywere to
compare the number of primary care visits one year before and after a hospitaliza-
tion, within hospitalized patients, and between non-hospitalized and hospitalized
patients (post hospitalization). METHODS: Data on hospital and primary care re-
source use among hypertensive patients (17 years) were extracted from elec-
tronic patient journals from 1999 through 2007. Differences in number of visits
prior to and post hospitalization, and between hospitalized and non-hospitalized
patients, were assessed using standard statistical tests. Propensity-scorematching
was used to account for differences in observable characteristics.RESULTS:Among
10,196 patients, 4,692 patients were hospitalized and 5,504 were not hospitalized.
During the year prior to hospitalization, hospitalized patients had a significantly
lower (p0.0001) mean number (SD) of total visits than in the post-hospitalization
year: 4.58 (7.75) versus 6.91 (12.12). Non-hospitalized patients had significantly
fewer (p0.0414) visits than hospitalized patients (post-hospitalization): 4.46 (4.28)
versus 6.91 (12.12). Results were qualitatively similar for GP and nurse visits, in
different subgroups (e.g. age, diabetes), and in patients without prior cardiovascu-
lar disease or cancer. Also when comparing propensity-matched (e.g. gender, geo-
graphic region) hospitalized and non-hospitalized patients, results remained sim-
ilar. The number of visits demonstrated a rising trend prior to hospitalization and
peaked during the three months post hospitalization. After three months, the
number of visits decreased yet stabilized at a higher level than before
hospitalization.CONCLUSIONS:Weshow that hospitalizations are associatedwith
significant subsequent increases in primary care resource use. This suggests that
investing in treatments that prevent hospitalizations could potentially reduce
overall costs in primary care while improving patient health.
PCV102
CHRONIC HEART FAILURE IN THE ELDERLY: COSTS AND RESOURCE
UTILIZATION FOLLOWING INITIAL HOSPITALIZATON
Eldar-lissai A1, Korves C1, Wei R1, Sharma H1, Chen K1, Ong SH2, Duh MS1
1Analysis Group, Inc., Boston, MA, USA, 2Novartis Pharma AG, Basel, Switzerland
OBJECTIVES: To determinemedical resource utilization and costs following hospi-
talization among elderly patients with chronic heart failure (HF). METHODS: Pa-
tients 65 years and older, with 1 hospitalization with a chronic HF diagnosis
(ICD-9 428.22, 428.32 or 428.42) were identified in the MarketScan® database be-
tween 2004 and 2008. Patients were observed starting 6 months prior to index
chronic HF hospitalization (IH) until disenrollment or end of data availability. Re-
source use and costs during IH and subsequent 4 HF re-hospitalizations were cal-
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